Opening Day: Immune-oncology company MAIA Biotechnology drops in market debut - InvestingChannel

Opening Day: Immune-oncology company MAIA Biotechnology drops in market debut

Shares of immune-oncology company MAIA Biotechnology dropped almost 15% in their trading debut on Thursday after the IPO priced at the low end of expectations. On the flip… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3555197/-Opening-Day-Immuneoncology-company-MAIA-Biotechnology-drops-in-market-debut)

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire